PATENT CLAIM ANALYSIS

Application Number: 15887105
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
A composition of furosemide, or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof is combined with a steroid, or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, to provide a topical medication for nasal or pulmonary treatment. The composition can provide, in a single administration or dosing regime, the anti-inflammatory properties of the steroid and the anti-inflammatory properties of furosemide, without any significant interference between the two, or adverse reaction in situ.

Claim (Index 20):
The method according to  claim 18  further comprising adding at least one of the following substances to the composition: an isotonization agent, a surfactant, a polar cosolvent, a thickening agent and a buffer.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.85417
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12879515', '13644127', '13644126', '12508388', '12508393']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7562737311569905
- 35 USC 102 Novelty (BERT): 0.4873155590816359
- Combined Prediction Score: 0.7293779139494551
- Mean Citation Score: 237.137514
- Max Citation Score: 239.27019
- Similarity Product: 191.85984794664145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test